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INTRODUCTION
All somatic cells proliferate using common mechanism of
mitosis following progression through the cell cycle. In addi-
tion, apoptosis or programmed cell death appears to be a ubiq-
uitous process in multicellular organisms to remove unwant-
ed or damaged cells (1, 2). As it is essential to identify and eli-
minate cells proliferating inappropriately, apoptosis and pro-
liferation are tightly coupled, and cell cycle regulators can influ-
ence both cell division and cell death (1). It is well understood
that cell cycle checkpoints monitor the timing and order of
cell cycle events, and these occur at the G1/S phase boundary,
in S phase, and during the G2 and M phases (2). These check-
points ensure that important events in each phase of the cell
cycle are completed before a new phase is initiated, thereby
preventing the formation of genetically abnormal cells. Dur-
ing G1, the cell decides whether to continue through the cell
cycle and divide, or leave the cell cycle and enter a state of qui-
escence (G0). Pardee further introduced the term restriction
(R) to define the point in G1, after which cells can prolifer-
ate independent of mitogenic stimuli, and also suggested the
importance of the R point in malignant transformation (3).
Proteins, which are involved in the G1 checkpoint include
p53, pRb, and the E2F family of transcription factors (4). The
p53 protein is thought to be an essential mediator that reg-
ulates the R point (5). The p53 protein is induced by DNA
damaging chemicals as well as by ionizing radiation. p53 is
required for G1 arrest and/or apoptosis following DNA dam-
age (6). p53 activates the transcription of several genes and the
best studied target molecule is p21WAF1/Cip1, which has a role
in p53-mediated G1 arrest (2). In addition, the expression of
the proapoptotic gene, bax, is upregulated by p53 induced
after DNA damage, and this upregulation causes apoptosis (7).
p53 induces apoptosis as well as G1 arrest, but G1 arrest is not
a prerequisite for p53 induced apoptosis. Cells from p21WAF1/Cip1
(-/-) mice, for example, exhibit a defect in p53 induced G1
arrest, but show normal p53-mediated apoptosis (8). There-
fore, p53 induction may cause G1 arrest or apoptosis, depend-
ing on the cell type.
Cells are able to undergo apoptosis in response to various
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Distinct Patterns of Cleavage and Translocation of Cell Cycle Control
Proteins in CD95-induced and p53-induced apoptosis
Apoptotic cell death induced by p53 occurs at a late G1 cell cycle checkpoint termed
the restriction (R) point, and it has been proposed that p53-induced apoptosis caus-
es upregulation of CD95. However, as cells with defective in CD95 signaling path-
way are still sensitive to p53-induced apoptosis, CD95 cannot be the sole factor result-
ing in apoptosis. In addition, unlike p53-induced apoptosis, the relationship between
CD95-mediated apoptosis and the cell cycle is not clearly understood. It would there-
fore be worth investigating whether CD95-mediated cell death is pertinent with p53-
induced apoptosis in view of cell cycle related molecules. In this report, biochemical
analysis showed that etoposide-induced apoptosis caused the induction and the
nuclear translocation of effector molecules involved in G1 cell cycle checkpoint. How-
ever, there was no such translocation in the case of CD95-mediated death. Thus,
although both types of apoptosis involved caspase activation, the cell cycle related
proteins responded differently. This argues against the idea that p53-induced apop-
tosis occurs through the induction of CD95/CD95L expression.
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stimuli (2, 4), including death receptor ligation, cytotoxic
drugs, ionizing radiation, and DNA damaging chemicals.
Among receptors that induce apoptosis, CD95 (Apo-1 or Fas)
is a member of the TNF receptor family, and is expressed on
various types of cells including thymocytes (9) and activated
T cells (10, 11). When CD95 interacts with its ligand (CD95L),
CD95 is trimerized and the trimer recruits an adaptor protein
Fas associated death domain (FADD), which in turn activates
caspase 8. This upstream or initiator caspase has two death
effector domains (DED) at its N-terminus (12). This leads to
the activation of other caspases, resulting in the cleavage of
multiple vital substrates and apoptosis (13). Many studies
have been focused on CD95-mediated death, but its relation-
ship with the cell cycle is still controversial. For instance, Dao
et al. reported that CD95-mediated death happens in G1 phase
suggesting that CD95-mediated death may mimic death at
the R point, while Boehme and Lenardo suggested that acti-
vation induced cell death (AICD) of T cells occurs in S phase
(14, 15).
It has been shown that p53 activation induces CD95 and/
or its ligand through a translation-independent pathway (16)
and transiently sensitizes cells to CD95-induced apoptosis
(16). However, this cannot be a general mechanism as etopo-
side-induced apoptosis can be CD95-independent (17, 18). For
example, cells without FADD or that express a dominant-neg-
ative FADD, and which are therefore defective in CD95 sig-
naling, are still sensitive to ionizing radiation and DNA-dam-
aging chemicals (19, 20). Furthermore, Chen and Tan report-
ed that induction of CD95 expression alone was not sufficient
to induce apoptosis in irradiated cells (18). Thus, the relation-
ship between CD95-induced and R checkpoint-based apop-
totic mechanisms needs to be understood. These findings pro-
mpted us to compare the biochemical basis of p53-induced
and CD95-induced apoptosis in T cells, with respect to cell
cycle control proteins.
Etoposide was used in this study to induce apoptosis, as it
is known to inhibit topoisomerase II and cause DNA double
strand breaks, which result in apoptosis mediated through
p53 induction (21). We chose Jurkat cells as target cells to
induce apoptosis as they are known to be sensitive to both
CD95 and etoposide mediated apoptosis (22). Thus, we have
studied the possible convergence of caspase-based and cell cycle
checkpoint-based apoptotic mechanisms in response to two
stimuli, CD95 ligation and etoposide treatment. We reasoned
that, if a CD95-based mechanism were the principal down-
stream effector of p53 induction, both etoposide-induced and
CD95-induced apoptosis would result in similar patterns of
substrate changes. However, the patterns we observed were
quite different. We found that DNA damage induced p53
and showed strong mobilization of cell cycle R checkpoint-
associated proteins to the cell nucleus, while no such move-
ments were seen in CD95-mediated apoptosis. This argues
against the idea that p53-induced apoptosis occurs through
the induction of CD95/CD95L expression.
MATERIALS AND METHODS
Cells and Reagents
Jurkat cells were maintained in RPMI1640 containing 10%
fetal calf serum (FCS, Hyclone Logan, UT, U.S.A.), 2 mM
L-glutamine, 50  M  -mercaptoethanol, 10 mM HEPES, and
100 U/mL each of penicillin and streptomycin. Polyclonal or
monoclonal antibodies against a number of cell cycle control
proteins were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, U.S.A.). They were anti-p53 (sc-126), anti-E2F-1
(sc-193), anti-E2F-4 (sc-866), anti-p21WAF1/Cip1 (sc-397), anti-
p27Kip-1 (sc-776), anti-CDK4 (sc-601), anti-p107 (sc-250), and
anti-pRb (sc-50) antibodies. Anti-mouse or anti-rabbit Ig anti-
serums coupled to horseradish peroxidase (HRP) were also from
Santa Cruz Biotechnology. Etoposide was purchased from Sig-
ma (St. Louis, MO, U.S.A.). The caspase inhibitors, z-VAD-
fmk and DEVD-CHO, were from Calbiochem (La Jolla, CA,
U.S.A.).
Cell Culture and Flow Cytometric Analysis
Jurkat cells were suspended at 0.5×106 cells/mL in a final
volume of 10 mL of RPMI culture medium, and layered over
control or CD95L-expressing fibroblasts (14) in 10 cm dish-
es (Falcon 35-3003, Becton-Dickinson, Franklin Lakes, NJ,
U.S.A.). At the indicated time points, non-adherent Jurkat
cells were harvested and then tested for apoptosis (using PI
staining to detect sub-diploid cells) or lysed for western blot
analysis. To detect sub-diploid cells, a suspension of cells were
incubated with propidium iodide (PI) at 50  g/mL (Sigma
Chemical Co.) for 30 min in 0.1% sodium citrate, 0.3% Non-
idet P-40, and 50  g/mL RNAse. PI stained cells were analyzed
using a FACScalibur (Becton-Dickinson, Mountain View, CA,
U.S.A.) and data were analyzed using Cellquest software.
Immunoblotting Analysis
Jurkat cells were centrifuged and then the cell pellet was
washed and lysed in the Laemmli buffer containing a protease
inhibitor cocktail (Boehringer Mannheim, Manheim, Ger-
many). In order to separate cytoplasmic and nuclear proteins,
Jurkat T cells were incubated with CD95L expressing fibro-
blasts, or treated with 50  M of etoposide, and subcellular frac-
tionation was performed as described previously (23). Briefly,
cells were lysed in a hypotonic buffer (10 mM HEPES-KOH,
pH 7.9; 10 mM KCl; 1.5 mM MgCl2; 0.5 mM dithiothreitol)
containing 0.1% Triton X-100, and fractionated by low speed
centrifugation into a low-salt-soluble supernatant for cytoplas-
mic proteins and an insoluble nuclear pellet. The insoluble
nuclear pellet fraction was extracted further with ELB (50 mM
HEPES, pH 7.2; 250 mM NaCl; 2 mM EDTA; 0.1% NP-40).
The protein concentration was checked by using BioRad solu-
tion (Bio-Rad DC Protein Assay Kit I, BioRad) and the sameamount of proteins were loaded onto 6, 10, 12, or 15% SDS-
PAGE gels, electrophoresed, and transferred to PVDF Immo-
bilon membranes (Millipore, Bedford, MA, U.S.A.) using an
electrotransfer apparatus from Bio-Rad (Hercules, CA, U.S.A.).
Transferred membranes were incubated with primary anti-
bodies recognizing each of the cell cycle related proteins for
1-3 hr at room temperature, followed by extensive washing.
Immune complexes were tagged using goat anti-rabbit or
rabbit anti-mouse HRP, then visualized using the enhanced
chemiluminescent (ECL) kit from Amersham Life Sciences
(Buckinghamshire, U.K.).
RESULTS
In order to determine the role of caspases in CD95 or etopo-
side-mediated apoptosis in Jurkat cells, the pan-caspase inhi-
bitor, z-VAD-fmk was added to cells subjected to either of
two death signals: CD95-engagement or etoposide treatment.
CD95 is known to activate caspase 8 through interaction of
its death domain with FADD while etoposide, a DNA dam-
aging agent, causes p53-induced cell death. In both cases, Jur-
kat cells underwent apoptosis which was verified by PI stain-
ing (Fig. 1). Upon CD95 ligation, Jurkat cells responded rapid-
ly as ~52% cells were subdiploid after the 5 hr incubation with
CD95L expressing fibroblasts. Etoposide induced cell death
was as extensive as that of CD95 ligation but it took 18 hr to
cause the same percentage of apoptotic cells (Fig. 2). In order
to examine whether caspases were the mediators of apoptosis
in both cases, the caspase-inhibitor, z-VAD-fmk, was added
at various concentrations. As shown in Fig. 1, z-VAD-fmk was
able to block apoptosis in both cases. However, CD95-induced
apoptosis was more sensitive to z-VAD-fmk inhibition, since
even 10  M z-VAD-fmk caused significant blockade of CD95-
induced Jurkat cell death, while significant blockade of etopo-
side-induced death required 40  M z-VAD-fmk.
In the case of CD95 mediated death, z-VAD-fmk blocks
the caspase 8 pathway and the subsequent cascade of caspase
activation. In etoposide treatment, it is known that p53 induc-
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Fig. 1. Apoptosis induced by CD95 ligation or etoposide treatment
in Jurkat cells. 50  M etoposide or co-culture of CD95L express-
ing fibroblasts was applied to induce apoptosis as described in
Material and Methods. 10-150  M of  z-VAD-fmk or same volume
of DMSO (control) was added to block the caspase activation. After
8 hr incubation, the degree of apoptosis was determined by count-
ing subdiploid cells by using a PI staining and analyzed by FAC-
Scalibur. open circle, Jurkat cells co-cultured with control fibrob-
lasts (vector 3T3 cells); closed circle, co-cultured with CD95L trans-
fected fibroblasts; open square, cultured in media containing DMSO;
and closed square, culture with 50  M of etoposide.
Fig. 2. The expression of cell cycle related proteins upon treatment
with apoptotic stimuli. For etoposide-induced apoptosis, Jurkat cells
were incubated in media containing 50  M etoposide for 18 hr.
Media alone was used as a control. To induce CD95 mediated de-
ath, Jurkat cells were co-cultured with CD95L-transfected fibrob-
lasts or control fibroblasts (vector-3T3). Apoptotic cells were cal-
culated by counting subdiploid cells using PI staining as described
in Material and Methods. In order to block caspase action, caspase
inhibitors, 50  M of either z-VAD-fmk or DEVD-CHO was added
before the induction of apoptosis. 30  g of protein extracts from
each sample was subjected to SDS-PAGE. The arrows indicate
each cell cycle protein. Overexposure of the p53 blot was used to
verify the induction of p53 in CD95-mediated apoptosis. p107 has
a caspase recognition site producing a 15 kDa C-terminal fragment
which is recognized by anti-p107 ab (sc-250) and is indeed visu-
alized by immunoblotting (p107 fragments).
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tion leads to bax expression that activates apoptosis (24).
In addition, it was reported that the expression of CD95/
CD95L was upregulated by p53 induced by DNA damaging
agents (16). However, it is controversial whether p53-medi-
ated death occurs through CD95-upregulation followed by its
engagement by simultaneously up-regulated CD95L. Further-
more, it is not known at which phase of the cycle cells become
targets for CD95 mediated apoptosis, nor how cell cycle-relat-
ed molecules would respond during apoptosis due to CD95
ligation in T cells. In the case of p53-mediated death, it is well
documented that apoptosis occurs at the R point which is G1/
S boundary (2). We reasoned that, if a CD95-based mechanism
were the principal downstream effector of p53 induction, both
etoposide induced and CD95-induced apoptosis would result
in similar pattern of substrate cleavage. In view of the contro-
versy surrounding the relationship between apoptosis and cell
cycle control, we focused on the cell cycle proteins that regu-
late G1 phase. These include p53, E2F-4, the cyclin-depen-
dent kinase inhibitors, p21WAF1/Cip1 and p27Kip-1, and the pock-
et protein, p107.
Fig. 2 shows the expression of these molecules in response
to CD95 ligation or treatment with etoposide. As expected,
strong induction of p53 was found in etoposide-treated cells,
while very little induction was seen in CD95 mediated death
even when a longer exposure time was used. This finding con-
firmed that etoposide induces classic p53-mediated apoptosis.
Furthermore, p21WAF1/Cip1was induced in both CD95 and etopo-
side mediated death, although the amount induced was much
higher in the case of etoposide treatment. This is also thought
to be p53 dependent. For p27Kip-1, both stimuli led to the de-
gradation of this protein. This could be caused by ubiquiti-
nation, or through caspase activity. In fact, it was shown that
p27Kip-1 is rapidly ubiquitinated during the G1-S transition
(25). However, it was recently reported that p27Kip-1 is cleaved
by caspase action, and that this resulted in increased cell death
in human epithelial cells (26). In Jurkat cells, caspase-medi-
ated breakdown of p27Kip-1 also appeared to be important, since
the loss of p27Kip-1 was inhibited by z-VAD-fmk.
The E2F family consists of 6 members, which act as tran-
scription factors. They are believed to be critically positive
regulators of cell cycle progression. Among them, E2F-1 either
induces or protects cells from apoptosis, depending on the cell
type and the apoptotic stimuli (27, 28). Although E2F-4 is
expressed in the early phases of the cell cycle and the expres-
sion continues throughout the cycle (29), the role of E2F-4 in
apoptosis is poorly understood. We were only able to detect
only trace amounts of E2F-1 in Jurkat cells, but E2F-4 was
abundant (Fig. 3). We therefore focused on the expression of
E2F-4, which might regulate G1 progression. In the exper-
iment shown in Fig. 2, there was not much difference in the
expression of E2F-4, although the density of the hyperphos-
phorylated form of the protein was slightly reduced. This was
possibly a result of cleavage by caspases, as there is a conserved
caspase-3 cleavage site at the C-terminus in all E2F family
members.
DISCUSSION
The pocket proteins are the partners of E2Fs. The retinoblas-
toma protein pRb interacts with E2F-1 to inhibit the func-
tion of E2F-1 from acting as a transcription factor, while the
pRb-related proteins, p107 and p130, bind to E2F-4. There-
fore, E2F-4 is thought to play a role in the transition from the
G0 to the G1 phase. As both CD95 and etoposide induce
apoptosis in G1 phase cells (2, 6, 13, 14, 30), we hypothesized
that E2F-4 could be involved in both apoptotic stimuli. Con-
sequently, p130 and/or p107 could be involved in both cases.
However, p130 is known to act on the G0-G1 transition, while
our main focus of interest is the G1/S transition. We there-
fore evaluated the expression and modulation of p107. All
pocket proteins have caspase-3 target sites, i.e., the DxxD motif,
and it is already known that pRb is cleaved during TNFR1
and CD95-mediated apoptosis (31). As shown in Fig. 2, a
15 kDa C-terminal cleavage product of p107 was detected
Fig. 3. Nuclear translocation of G1 cell cycle proteins. Etoposide
and CD95 ligation were applied as described in Fig. 2. At the indi-
cated time point, Jurkat cells were pelleted and cytoplasm and nu-
clear proteins were fractionated as described in Material and Meth-
ods. 30 g  of  each sample (either cytoplasm or nuclei) were sep-
arated and immunoblotting was performed with the antibodies indi-
cated. C: cytoplasmic extracts, N: nuclear extracts. Arrows indicate
each cell cycle protein and arrowheads in the p27
Kip-1 blot are be-
lieved to indicate caspase-cleaved fragments.
p21
Cip-1
p27
Kip-1
Etoposide, 50  M
C NCNC N C N C N CNC N CN
cont 5 hrs 8 hrs o/n cont 5 hrs 8 hrs o/n
CD95 Iigation
E2F-1
E2F-4
pRb
p107
cdk-4
△
△during apoptosis due to either CD95 ligation or treatment
with etoposide. This seemed to be produced by caspase activ-
ity, as in CD95-ligated cells the cleavage was completely inhib-
ited by z-VAD-fmk. This is the first demonstration that, in
addition to pRb, p107 is one of the substrates of caspase(s)
activated upon CD95 ligation.
There were subtle differences between CD95-induced and
etoposide mediated apoptosis in Jurkat T cells (Fig. 2). One
noteworthy detail was that the breakdown of p107 was inhib-
ited completely by 50  M z-VAD-fmk in the case of CD95-
induced apoptosis, but only inhibited partially by the same
concentration of z-VAD-fmk in etoposide mediated apopto-
sis. This is a hint that a different spectrum of caspases might
be involved in the two different types of apoptosis.
The biological activity of cell cycle control proteins at the
G1/S checkpoint is associated with their translocation into the
nucleus (1, 5). To test whether this mechanism was operating
in Jurkat cells undergoing apoptosis, we examined nuclear vs.
cytoplasmic lysates of Jurkat cells during CD95-induced and
etoposide-induced apoptosis. Fig. 3 showed the differential
translocation of several proteins upon etoposide treatment or
CD95 ligation. Interestingly, there was no translocation of
p27Kip-1 into the nucleus although it has a nuclear localization
signal. This suggests that other proteins such as cyclin and/or
CDK might regulate the intracellular location of p27Kip-1. The
E2F-1 protein did not move into the nucleus upon apoptotic
signals, and therefore, it was probably not able to act as a tran-
scription factor under these conditions. In accordance with
this, the natural interaction partner of E2F-1, pRb, did not
move into the nucleus in either case. In addition, pRb disap-
peared over 8 hr during etoposide mediated cell death. There-
fore, the E2F-1/pRb complex was unlikely to be a mediator
in either of these apoptotic signals. This is surprising, as E2F-
1-induced cell death is thought to be important in T cells (27).
E2F-1 deficient mice exhibit a defect in T lymphocyte devel-
opment leading to an excess of mature T cells due to defective
apoptosis in the thymus (27). Furthermore, it was reported
that E2F-1 overexpression causes increased S phase and apop-
tosis (32), while pRb inhibits both processes (4, 33). However,
it is possible that the apoptotic activity of E2F-1 is restricted
to certain forms of apoptosis that occur in S phase. As CD95
and p53-mediated apoptosis are supposed to occur in G1 phase
or during the G1-S transition, cell cycle proteins regulating
G1 phase would be more likely to play a role in apoptosis due
to these causes. We therefore think that at least in Jurkat cells,
E2F-1-mediated cell death is not the same as G1/S checkpoint
death.
There is no concrete evidence that specifically implicates
E2F-4 in apoptosis. As mentioned above, p107 is expressed
and functional in the G1 phase of the cycle (4). Therefore, it
would be informative to determine whether there is differen-
tial regulation of this molecule in response to the two distinct
apoptotic signals. Among the cell cycle control proteins test-
ed, three molecules were differentially translocated in the two
different types of apoptosis: p21WAF1/Cip-1, E2F-4 and p107.
Those molecules were translocated to the nucleus in etopo-
side-induced apoptosis, but not in CD95-induced apoptosis.
In the case of etoposide treatment, the translocation of those
molecules could be the result of a G1/S checkpoint, induced
through p53. In the mouse system, TCR mediated death is
thought to happen in late G1 phase (30), although this is con-
troversial (15) and there is evidence that CD95-mediated death
also happens in G1 (13, 14). However, at least in Jurkat cells,
our data show that there is no movement of the G1 cell cycle
proteins during CD95-induced apoptosis. This implies that
CD95-mediated death does not involve the same mechanism
as apoptosis associated with the G1-checkpoint. While sever-
al previous reports document that etoposide treatment induces
CD95/CD95L expression, this may not be the general mech-
anism of etoposide-induced death in most cell types. In sup-
port of this argument, the cells from FADD deficient mice
are apoptotic in response to DNA damaging agents (19, 20).
Also, thymocytes from p53 deficient mice are sensitive to
CD95-mediated death (34).
In summary, we compared the response of cell cycle control
proteins to two different apoptotic stimuli, CD95 ligation
and treatment with etoposide. Although both pathways were
mediated by caspases, the translocation of cell cycle control
proteins, especially the G1/S checkpoint-associated G1 mo-
lecules, was different. Etoposide induced p53 and showed the
p53 dependent, G1/S checkpoint-associated pattern of nucle-
ar translocation of E2F-4, p21WAF1/Cip-1, and p107. In contrast,
in CD95 mediated death, there was no translocation of G1/S
cell cycle proteins. This suggests that CD95 ligation does not
involve the G1/S checkpoint cell cycle control proteins to
induce cell death. In addition, while p53 induction may result
in CD95/CD95L expression in some systems, it is not the main
pathway through which p53 induces apoptosis.
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